Literature DB >> 18523068

Molecular imaging of metastatic potential.

Paul T Winnard1, Arvind P Pathak, Surajit Dhara, Steven Y Cho, Venu Raman, Martin G Pomper.   

Abstract

If molecular imaging is to prove clinically useful it will have to surpass current, primarily anatomic techniques in terms of sensitivity and the ability to detect minimal changes in tissue. One of the most important tests for molecular imaging is to determine whether it can image the metastatic potential of tumors. Like all predictive endeavors, the imaging of such "potential" is a daunting task, but one that only molecular imaging--rather than standard, anatomic techniques--is likely to solve. Although difficult, imaging of metastatic potential is also arguably the most important task for molecular imaging of cancer because it is generally the dissemination of malignant tissue, not its prolonged residence in an inopportune site, which kills the patient. Below are examples of uses of molecular imaging of metastases as well as of metastatic potential, the former being a far more developed area of clinical inquiry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523068      PMCID: PMC5516907          DOI: 10.2967/jnumed.107.045948

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  191 in total

Review 1.  Targeted in vivo imaging of angiogenesis: present status and perspectives.

Authors:  Yearn Seong Choe; Kyung-Han Lee
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

2.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

Authors:  Roderick J Phillips; Marie D Burdick; Marin Lutz; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

Review 3.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

Review 4.  Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.

Authors:  Shuang Liu
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

Review 5.  Imaging hypoxia and angiogenesis in tumors.

Authors:  Joseph G Rajendran; Kenneth A Krohn
Journal:  Radiol Clin North Am       Date:  2005-01       Impact factor: 2.303

6.  Firefly luciferase is targeted to peroxisomes in mammalian cells.

Authors:  G A Keller; S Gould; M Deluca; S Subramani
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Bioluminescent monitoring of islet graft survival after transplantation.

Authors:  Yuxin Lu; Hoa Dang; Blake Middleton; Zesong Zhang; Lorraine Washburn; Martha Campbell-Thompson; Mark A Atkinson; Sanjiv Sam Gambhir; Jide Tian; Daniel L Kaufman
Journal:  Mol Ther       Date:  2004-03       Impact factor: 11.454

8.  Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.

Authors:  Tatsuo Umeoka; Takeshi Kawashima; Shunsuke Kagawa; Fuminori Teraishi; Masaki Taki; Masahiko Nishizaki; Satoru Kyo; Katsuyuki Nagai; Yasuo Urata; Noriaki Tanaka; Toshiyoshi Fujiwara
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

9.  The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

Authors:  Angela van Baardwijk; Christophe Dooms; Robert Jan van Suylen; Erik Verbeken; Monique Hochstenbag; Cary Dehing-Oberije; Dennis Rupa; Silvia Pastorekova; Sigrid Stroobants; Ulrich Buell; Philippe Lambin; Johan Vansteenkiste; Dirk De Ruysscher
Journal:  Eur J Cancer       Date:  2007-05-23       Impact factor: 9.162

Review 10.  Diagnostic and therapeutic management of cancer of an unknown primary.

Authors:  N Pavlidis; E Briasoulis; J Hainsworth; F A Greco
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

View more
  20 in total

1.  In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.

Authors:  Viviane Mumprecht; Michael Honer; Benjamin Vigl; Steven T Proulx; Eveline Trachsel; Manuela Kaspar; Nadja E Banziger-Tobler; Roger Schibli; Dario Neri; Michael Detmar
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

2.  Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide.

Authors:  Fan Zhang; Gang Niu; Xin Lin; Orit Jacobson; Ying Ma; Henry S Eden; Yulong He; Guangming Lu; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2011-07-19       Impact factor: 3.520

3.  Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.

Authors:  Yongfeng Zhao; Lisa Detering; Deborah Sultan; Matthew L Cooper; Meng You; Sangho Cho; Stephanie L Meier; Hannah Luehmann; Guorong Sun; Michael Rettig; Farrokh Dehdashti; Karen L Wooley; John F DiPersio; Yongjian Liu
Journal:  ACS Nano       Date:  2016-05-18       Impact factor: 15.881

4.  Quantitative mitochondrial redox imaging of breast cancer metastatic potential.

Authors:  He N Xu; Shoko Nioka; Jerry D Glickson; Britton Chance; Lin Z Li
Journal:  J Biomed Opt       Date:  2010 May-Jun       Impact factor: 3.170

Review 5.  Current progress of aptamer-based molecular imaging.

Authors:  Andrew Z Wang; Omid C Farokhzad
Journal:  J Nucl Med       Date:  2014-02-13       Impact factor: 10.057

6.  Neoplastic transformation of breast epithelial cells by genotoxic stress.

Authors:  Mahendran Botlagunta; Paul T Winnard; Venu Raman
Journal:  BMC Cancer       Date:  2010-06-30       Impact factor: 4.430

Review 7.  Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents.

Authors:  Jingjuan Qiao; Shenghui Xue; Fan Pu; Natalie White; Jie Jiang; Zhi-Ren Liu; Jenny J Yang
Journal:  J Biol Inorg Chem       Date:  2013-12-24       Impact factor: 3.358

8.  Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation.

Authors:  Nathaniel E Margolis; Linda Moy; Eric E Sigmund; Melanie Freed; Jason McKellop; Amy N Melsaether; Sungheon Gene Kim
Journal:  Clin Nucl Med       Date:  2016-08       Impact factor: 7.794

9.  Translation in solid cancer: are size-based response criteria an anachronism?

Authors:  M Fernandes; D Rosel; J Brábek
Journal:  Clin Transl Oncol       Date:  2014-07-30       Impact factor: 3.405

Review 10.  Aptamers Selected by Cell-SELEX for Molecular Imaging.

Authors:  Cheng Jin; Jing Zheng; Chunmei Li; Liping Qiu; Xiaobing Zhang; Weihong Tan
Journal:  J Mol Evol       Date:  2015-11-19       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.